secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0000950170-24-069945
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical shareholders elect directors, approve equity awards at annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected: Louis Panaccio, James Corbett, Jeremy Curnock Cook, Suzanne Crowe, Jan Stern Reed, Robert McNamara, Cary Vance.
- Stockholders approved RSUs valued at $87,500 and options valued at $37,500 for each non-executive director.
- CEO James Corbett granted options to acquire 350,000 shares of common stock, approved by shareholders.
- Non-binding advisory vote on named executive officer compensation passed (10,269,125 for, 2,296,661 against).
- Ratification of Grant Thornton LLP as independent auditor for FY2024 approved (14,794,234 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000095017024069945/0000950170-24-069945-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000095017024069945/rcel-20240605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-069945

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer